ASTRAZEN Share Price Target 2050

CAGR-based price projection for AstraZeneca Pharma India Limited (ASTRAZEN) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (-5.0% CAGR)
Rs 1,761
2050 Target
Base Case (-27.3% CAGR)
Rs 3
2050 Target
Bull Case (-41.0% CAGR)
Rs 0
2050 Target

Current Market Snapshot

CMP: Rs 6,031.00
52W High: Rs 8,962.50
52W Low: Rs 6,031.00
1Y CAGR: -47.2%
3Y CAGR: -27.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 5,729 Rs 4,383 Rs 3,559
2028 Rs 5,443 Rs 3,185 Rs 2,100
2029 Rs 5,171 Rs 2,315 Rs 1,239
2030 Rs 4,912 Rs 1,682 Rs 731
2031 Rs 4,667 Rs 1,222 Rs 431
2032 Rs 4,433 Rs 888 Rs 255
2033 Rs 4,212 Rs 646 Rs 150
2034 Rs 4,001 Rs 469 Rs 89
2035 Rs 3,801 Rs 341 Rs 52
2036 Rs 3,611 Rs 248 Rs 31
2037 Rs 3,430 Rs 180 Rs 18
2038 Rs 3,259 Rs 131 Rs 11
2039 Rs 3,096 Rs 95 Rs 6
2040 Rs 2,941 Rs 69 Rs 4
2041 Rs 2,794 Rs 50 Rs 2
2042 Rs 2,654 Rs 36 Rs 1
2043 Rs 2,522 Rs 27 Rs 1
2044 Rs 2,396 Rs 19 Rs 0
2045 Rs 2,276 Rs 14 Rs 0
2046 Rs 2,162 Rs 10 Rs 0
2047 Rs 2,054 Rs 7 Rs 0
2048 Rs 1,951 Rs 5 Rs 0
2049 Rs 1,854 Rs 4 Rs 0
2050 Rs 1,761 Rs 3 Rs 0

Other ASTRAZEN Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the ASTRAZEN share price target for 2050?

Based on historical growth analysis, the ASTRAZEN share price target for 2050 ranges from Rs 1,761 (conservative) to Rs 3 (base case) to Rs 0 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of ASTRAZEN?

The current market price of ASTRAZEN (AstraZeneca Pharma India Limited) is Rs 6,031.00. The 52-week high is Rs 8,962.50 and 52-week low is Rs 6,031.00.

Is ASTRAZEN a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for ASTRAZEN price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -5.0% CAGR), Base (-27.3% CAGR), and Bull (optimistic at -41.0% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.